Summary Mean values of extracellular pH (pH,) in tumours tend to be about 0.5 pH units lower than in normal tissues, whereas values of intracellular pH (pHi) in tumours and normal tissues are similar. Previous studies have shown that drugs that acidify cells at lower pHe such as nigericin, used alone or with agents that inhibit the regulation of pH,, have toxicity to cultured cells at pH,<6.5 in short-term exposure; these agents also lead to modest anti-tumour effects in mice when given acutely. To evaluate the long-term effects of these drugs at levels of pHe that might occur commonly in tumours, we exposed cells for up to 72 h at pHe 6.8 or 7.2 in vitro. Nigericin (0.033 gM) caused time-dependent cell killing of murine KHT and EMT-6 cells at pHe 6.8 (but not at pHe 7.2) with a surviving fraction approximately 5 x 10-3 after 72 h exposure. Cell killing was increased in the presence of 4,4-diisothiocyanstilbene 2,2-disulphonic acid (DIDS), an inhibitor of Na+-dependent HCO3-/Cl-exchange, and to a lesser extent in the presence of 5-(N-ethyl-N-isopropyl) amiloride (EIPA), an inhibitor of Na+/H+ exchange. Cell killing was exquisitely sensitive to the level of pHe. Osmotic pumps were used to obtain a 72 h continuous infusion of nigericin in mice; this led to dose-dependent killing of cells in KHT tumours with surviving fraction of approximately 0.1 at maximum tolerated doses. Hydralazine, which may cause tumour hypoxia and lower pHi as well as pH,, caused cytotoxity when given alone by chronic infusion, and enhanced the cytotoxicity due to nigericin. The addition of DIDS and/or EIPA (using two pumps) further enhanced anti-tumour toxicity, with a surviving fraction of approximately 0.002 at tolerated doses of the four drugs used to treat KHT tumours. The experiments demonstrate the activity of drugs that inhibit the regulation of pHi against murine tumours when delivered by chronic infusion.
Limited vascularisation of solid tumours often leads to inadequate delivery of oxygen and other nutrients to some tumour cells and to poor clearance of metabolic products as compared with normal tissues (Tannock, 1968) . Tumour cells tend to metabolise glucose by glycolysis even under welloxygenated conditions. Especially in hypoxic regions, tumour cells depend on anaerobic glycolysis as an energy source with consequent production of lactic acid, and clearance of this and other acids produced by metabolism may lead to tumour acidity. Measurements of extracellular pH (pHe) using microelectrodes have shown that the pHe of tumours is on average about 0.5 pH units lower than that of normal tissues, with tumour pHe typically in the range 6.6-7.0 and normal tissue pHe between pH, 7.1 and 7.6 (Wike-Hooley et al., 1984) . Although pH, in solid tumours tends to be acidic, intracellular pH (pH,) measured by 3"P-nuclear magnetic resonance (NMR) spectroscopy is usually found to have similar values in solid tumours and normal tissues (Vaupel et al., 1989) . Gillies et al. (1994) have measured pH, and pHe in tumours simultaneously using an extracellular pH marker and confirmed that tumour pHe was about 0.5 pH units lower than pHi in the same tumour. These results indicate that tumour cells are exposed frequently to an acidic environment and that the cells have active mechanisms that regulate their pH, to physiological levels.
The difference in pH, between tumours and normal tissues provides an opportunity for tumour-selective therapy through the development of drugs that have increased toxicity at low PHe (Tannock and Rotin, 1989) . Agents with this property include ionophores, such as nigericin, which abolish the pH gradient across the cell membrane. The viability of cells in an acidic microenvironment also depends on the activity of membrane-based exchangers that regulate pHi . Two major exchangers known to be involved in the regulation of pH, under acidic conditions are the Na+/H+ antiport (Johnson and Epel, 1976; Aronson et al., 1982; Moolenaar et al., 1984) and the Na+-dependent HCO3 /Cl1 exchanger (Thomas, 1977; L'Allemain et al., 1985; Cassel et al., 1988) . The former is inhibited by amiloride and its substituted analogues, and the latter is inhibited by stilbene derivatives such as DIDS (4,4-diisothiocyanstilbene 2,2-disulphonic acid).
Our previous studies have shown that the ionophore nigericin leads to intracellular acidification and is toxic to tumour cells under acidic conditions in vitro (Rotin et al., 1987) . Nigericin also causes cellular acidification in a murine tumour, and when combined with hydralazine, which decreases tumour blood flow, leads to killing of tumour cells (Newell et al., 1992) . In a previous study comparing three analogues of amiloride, 5-(N-ethyl-N-isopropyl) amiloride (EIPA) was found to be 200-fold more potent than amiloride in inhibiting Na+/H+ antiport activity (Maidorn et al., 1993) . Increased killing of tumour cells was found after injection of nigericin, EIPA and hydralazine into mice, but the surviving fraction was generally > 10' (Hasuda et al., 1994) . Others have shown that the combination of nigericin and DIDS augments the effect of hyperthermia on tumour growth when both drugs are given before heating an experimental tumour (Lyons et al., 1993) .
Previous experiments have studied the effects of agents such as nigericin, EIPA or DIDS, given as short-term exposures of up to 6 h in vitro or by bolus injection in vivo. Major toxicity in cell culture has been observed at pH. <6.5 but, as tumour pH, is generally higher than 6.5, it is not surprising that only limited cell kill has been observed in vivo. Long-term exposure to amiloride has been shown to cause the inhibition of proliferation of cells in culture (SzolgayDaniel et al., 1991 For continuous infusion, the concentration of hydralazine in osmotic pumps that were implanted in the peritoneal cavity was 12.5 mgml-'.
Results
Assessment of exchangers Table I shows rates of H+ efflux in KHT and EMT-6 cells.
When the cells were acidified to pHi 6.5, the rate of H+ efflux via the Na+/H+ exchanger was higher than that via the Na+-dependent HCO3-/Cl-exchanger in both cell lines. As expected (Boyer and Tannock, 1992) , the activity of both exchangers tended to be lower in the cell lines at pHi 6.8 than at pHi 6.5, but the Na+-dependent HCO3-/Cl-exchanger was then quantitatively more important.
In vitro studies added to the pumps death of the animals was observed; this compared with a maximum tolerated dose of 2.5 mg kg-1 nigericin by bolus injection (Hasuda et al., 1994) . Neither weight loss nor abnormal behaviour was observed with administration up to 2 mg ml-' nigericin and 10 mg ml-' DIDS from the osmotic pumps. Our unpublished data on pharmacokinetics of EIPA show a half-life of about 30 min in plasma of mice with slow conversion to the less potent amiloride, the concentration of which is still lower than that of EIPA up to 2 h later. Although EIPA administered from osmotic pumps containing a concentration of 3 mg ml-' was not toxic to mice, the combination of nigericin + DIDS + hydralazine + EIPA caused death of Balb/c mice implanted with EMT-6 tumours. Figure 5a . Continuous administration of nigericin caused significant delay of tumour growth, which was enhanced in the presence of DIDS. The mean rate of regrowth was also slower than that of control tumours after these treatments. Figure 5b shows the surviving fraction per tumour: nigericin caused dose-dependent killing of KHT cells in mice when given by 72 h infusion, although the effect of nigericin at the highest tolerated dose was to reduce survival only to approximately 10'1. There was slight enhancement of cell killing in the presence of DIDS. The relationship between growth delay and surviving fraction is known to be compex owing to cell killing, environmental effects on potentially lethal damage, anti-proliferative effects and the proliferation and removal of damaged cells. The differences in survival fraction between each treated group and control shown in Figure 5b are consistent with or greater than the difference in tumour weight after 72 h treatment, which is shown in Figure 5a pH, after bolus injection was observed only up to 4 h with a maximal decrease at 2 h after injection, whereas that obtained by continuous infusion lasted throughout the period of infusion. Table II indicates surviving fractions of cells in KHT and EMT-6 tumours of mice treated with continuous 72 h infusions of nigericin, hydralazine and DIDS via two infusion pumps. Mice were able to tolerate this combination of drugs and there were no animal deaths up to 2 weeks. The combination of nigericin and hydralazine caused an approximately 2-fold increase in cell killing as compared with nigericin alone. If DIDS was given with this combination of agents, the surviving fraction per tumour was reduced to about 0.02-0.03.
When EIPA was added to the second osmotic pump together with DIDS, this led to death of Balb/c mice implanted with EMT-6 tumours. C3H mice bearing KHT tumours were able to tolerate this treatment. EIPA caused a marked augmentation in cell killing by the combination of nigericin, DIDS and hydralazine with a surviving fraction per tumour reduced approximately 10-fold compared with the combination of the drugs without EIPA.
Discussion
The ionophore nigericin, which lowers pHi by allowing exchange of intracellular K+ for extracellular H+, has been shown to be cytotoxic to cultured cells at pHe.<6.5 (Rotin et al., 1987) . The average values of pHe in solid tumours, however, are usually about pHe 6.9, which is only 0.4-0.5 pH units lower than those in normal tissues (WikeHooley et al., 1984) . These values can be lowered slightly by vasodilator drugs (Newell et al., 1992) or by infusion of glucose with or without insulin (Hwang et al., 1991; Jahde et al., 1992) . In the present study, pH, 6.8 was selected as representative of the pHe that might be achieved in tumours, and long-term exposures of up to 72 h to low concentrations of nigericin were shown to kill tumour cells at pHe 6.8 in vitro. This observation indicates the potential for continuous administration of nigericin to kill cells in solid tumours as compared with normal tissues based on differences in pHe (6.8 vs 7.2).
We attempted to enhance the cytotoxicity of nigericin with DIDS, which is an inhibitor of the Na+-dependent HCO3-/ Cl-exchanger, and with EIPA, which is an inhibitor of the Na+/H+ exchanger, as both of the exchangers may have important roles in regulating pHi under acidic conditions (Cassel et al., 1988; Grinstein et al., 1989) . In previous experiments, short-term exposure to EIPA or DIDS increased the killing of tumour cells by nigericin (Maidorn et al., 1993; Luo and Tannock, 1994) when used at pHe 6.5. We measured the activity of both exchangers and confirmed our previous Our in vivo experiments have shown that chronic administration of nigericin can lead to a decrease in surviving fraction in both KHT and EMT-6 tumours, and that this effect is augmented by hydralazine, which inhibits tumour blood flow and lowers tumour pHi as well as pHe (Bhujwalla et al., 1990) . The increase in cell killing caused by hydralazine could be due to acidification of tumour or to There is evidence that the acute administration of agents that acidify cells may enhance the effects of hyperthermia against experimental tumours (Miyakoshi et al.. 1986 : Ruifrok et al.. 1987 : Song et al.. 1993 ). Our current results using chronic administration of such agents might hav-e relev,ance to studies of hyperthermia. although repeated or prolonged heat treatments within 72 h w-ould only be useful if thermotolerance were inhibited.
The potential for using continuous infusion of drugs in patients is greater than in small animals. in which multiple infusions are technically difficult. Our experiments have shown: (i) the feasibility of selective cell killing in culture at pH, 6.8. a value that may be representative for some regions of solid tumours. and (ii) the ability to obtain anti-tumour effects in an animal model. The exquisite sensitiVity of cell survival to pH, at values close to 6.8 suggests the potential for enhancing therapeutic effects through mechanisms that lower tumour pHe slightly and or for using alternative measures to kill non-acidic tumour cells. Such experiments are in progress in our laboratory. pHe. extracellular pH: pH,. intracellular pH.
